About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The
ODYSSEY DM‐INSULIN
randomized trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.